Rockwell Medical (RMTI) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.87 Mn | 5.07 Mn | 3.24 Mn | 20.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 68.13% |
| Mar 31, 2026 | 57.60% |
| Dec 31, 2025 | -26.08% |
| Sep 30, 2025 | 28.32% |
| Jun 30, 2025 | 51.95% |
| Mar 31, 2025 | 41.44% |
| Dec 31, 2024 | 26.60% |
| Sep 30, 2024 | 33.45% |
| Jun 30, 2024 | 27.86% |
| Mar 31, 2024 | 37.42% |
| Dec 31, 2023 | 60.96% |
| Sep 30, 2023 | 27.88% |
| Jun 30, 2023 | 16.82% |
| Mar 31, 2023 | 42.92% |
| Dec 31, 2022 | 30.87% |
| Sep 30, 2022 | 21.46% |
| Jun 30, 2022 | 22.91% |
| Mar 31, 2022 | 9.97% |
| Sep 30, 2021 | 5.79% |
| Jun 30, 2021 | 11.76% |